These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems. Cantón R; Oliver A; Alós JI; de Benito N; Bou G; Campos J; Calvo J; Canut A; Castillo J; Cercenado E; Domínguez MÁ; Fernández-Cuenca F; Guinea J; Larrosa N; Liñares J; López-Cerero L; López-Navas A; Marco F; Mirelis B; Moreno-Romo MÁ; Morosini MI; Navarro F; Oteo J; Pascual Á; Pérez-Trallero E; Pérez-Vázquez M; Soriano A; Torres C; Vila J; Martínez-Martínez L Enferm Infecc Microbiol Clin (Engl Ed); 2020 Apr; 38(4):182-187. PubMed ID: 30878313 [TBL] [Abstract][Full Text] [Related]
24. Raising the Bar: Improving Antimicrobial Resistance Detection by Clinical Laboratories by Ensuring Use of Current Breakpoints. Simner PJ; Rauch CA; Martin IW; Sullivan KV; Rhoads D; Rolf R; She R; Souers RJ; Wojewoda C; Humphries RM Open Forum Infect Dis; 2022 Mar; 9(3):ofac007. PubMed ID: 35146049 [TBL] [Abstract][Full Text] [Related]
25. European standards for antibiotic susceptibility testing: towards a theoretical consensus. Baquero F Eur J Clin Microbiol Infect Dis; 1990 Jul; 9(7):492-5. PubMed ID: 2226478 [TBL] [Abstract][Full Text] [Related]
26. Validation of novel cost-effective antimicrobial gradient strips for the determination of carbapenem susceptibility in Enterobacteriaceae. Sekar R; Srivani S; Lallitha S; Thenmozhi P; Devisri T; Amudhan M; Mythreyee M J Glob Antimicrob Resist; 2017 Mar; 8():97-101. PubMed ID: 28024980 [TBL] [Abstract][Full Text] [Related]
28. National Antimicrobial Resistance Monitoring System: Two Decades of Advancing Public Health Through Integrated Surveillance of Antimicrobial Resistance. Karp BE; Tate H; Plumblee JR; Dessai U; Whichard JM; Thacker EL; Hale KR; Wilson W; Friedman CR; Griffin PM; McDermott PF Foodborne Pathog Dis; 2017 Oct; 14(10):545-557. PubMed ID: 28792800 [TBL] [Abstract][Full Text] [Related]
29. [Recommendations for selecting antimicrobial agents for in vitro susceptibility studies using automatic and semiautomatic systems]. Cantón R; Alós JI; Baquero F; Calvo J; Campos J; Castillo J; Cercenado E; Domínguez MA; Liñares J; López-Cerezo L; Marco F; Mirelis B; Morosini MI; Navarro F; Oliver A; Pérez-Trallero E; Torres C; Martínez-Martínez L; Enferm Infecc Microbiol Clin; 2007; 25(6):394-400. PubMed ID: 17583653 [TBL] [Abstract][Full Text] [Related]
30. Who defines resistance? The clinical and economic impact of antimicrobial susceptibility testing breakpoints. Jorgensen JH Semin Pediatr Infect Dis; 2004 Apr; 15(2):105-8. PubMed ID: 15185194 [TBL] [Abstract][Full Text] [Related]
31. Performance of Vitek 2 for antimicrobial susceptibility testing of Enterobacteriaceae with Vitek 2 (2009 FDA) and 2014 CLSI breakpoints. Bobenchik AM; Deak E; Hindler JA; Charlton CL; Humphries RM J Clin Microbiol; 2015 Mar; 53(3):816-23. PubMed ID: 25540403 [TBL] [Abstract][Full Text] [Related]
32. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503 [TBL] [Abstract][Full Text] [Related]
33. FDA reveals plans for antimicrobial susceptibility monitoring. Tollefson L J Am Vet Med Assoc; 1996 Feb; 208(4):459-60. PubMed ID: 8603884 [No Abstract] [Full Text] [Related]
34. Standardization of antimicrobial susceptibility testing. Barry AL Clin Lab Med; 1989 Jun; 9(2):203-19. PubMed ID: 2659241 [TBL] [Abstract][Full Text] [Related]
35. [Layout proposal for a microtitre plate to be used in routine antimicrobial susceptibility testing of bacteria from infections of dogs and cats]. Werckenthin C; Luhofer G; Böttner A; Gangl A; Goossens L; Hafez HM; Hartmann K; Kaske M; Kehrenberg C; Kietzmann M; Klarmann D; Klein G; Krabisch P; Kühn T; Richter A; Schulz B; Schwarz S; Sigge C; Traeder W; Waldmann KH; Jürgen W; ; Berl Munch Tierarztl Wochenschr; 2008; 121(1-2):19-26. PubMed ID: 18277776 [TBL] [Abstract][Full Text] [Related]
36. [Antimicrobial susceptibility testing of bacteria isolated from animals: considerations concerning the predefinition of breakpoints from the clinical pharmacological viewpoint]. Kietzmann M; Böttner A; Hafez HM; Kehrenberg C; Klarmann D; Krabisch P; Kühn T; Luhofer G; Richter A; Schwarz S; Traeder W; Waldmann KH; Wallmann J; Werckenthin C; ; Berl Munch Tierarztl Wochenschr; 2004; 117(3-4):81-7. PubMed ID: 15046455 [TBL] [Abstract][Full Text] [Related]
37. Updating breakpoints in the United States: a summary from the ASM Clinical Microbiology Open 2022. Patel JB; Alby K; Humphries R; Weinstein M; Lutgring JD; Naccache SN; Simner PJ J Clin Microbiol; 2023 Oct; 61(10):e0115422. PubMed ID: 37791777 [TBL] [Abstract][Full Text] [Related]
38. Pan-European resistance monitoring programmes encompassing food-borne bacteria and target pathogens of food-producing and companion animals. de Jong A; Thomas V; Klein U; Marion H; Moyaert H; Simjee S; Vallé M Int J Antimicrob Agents; 2013 May; 41(5):403-9. PubMed ID: 23394810 [TBL] [Abstract][Full Text] [Related]
39. [A new SIR definition for antimicrobial susceptibility testing]. Giske C; Hanberger H; Kahlmeter G Lakartidningen; 2019 Jan; 116():. PubMed ID: 30720858 [TBL] [Abstract][Full Text] [Related]
40. Antimicrobial susceptibility testing in biofilm-growing bacteria. Macià MD; Rojo-Molinero E; Oliver A Clin Microbiol Infect; 2014 Oct; 20(10):981-90. PubMed ID: 24766583 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]